1993
DOI: 10.1006/geno.1993.1334
|View full text |Cite
|
Sign up to set email alerts
|

Localization of a Gene (CMT2A) for Autosomal Dominant Charcot-Marie-Tooth Disease Type 2 to Chromosome 1p and Evidence of Genetic Heterogeneity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
64
0
2

Year Published

1993
1993
2013
2013

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 143 publications
(66 citation statements)
references
References 0 publications
0
64
0
2
Order By: Relevance
“…These include Charcot-Marie-Tooth type 2A (16), neuroblastoma (30), diabetes susceptibility (Idd9) (31), and resistance to plasmacytoma (Pctr2) (32).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…These include Charcot-Marie-Tooth type 2A (16), neuroblastoma (30), diabetes susceptibility (Idd9) (31), and resistance to plasmacytoma (Pctr2) (32).…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, an axonal form of Charcot-Marie-Tooth (CMT2A) characterized by axonal loss, has been mapped to the homologous location in humans, 1p36 (16). This paper reports the identification and characterization of a tandem triplication within the Wld s candidate region.…”
mentioning
confidence: 99%
“…CMT1 is the demyelinating form, characterized by motor nerve conduction velocity (MNCV) below 35 m/s, whereas CMT2 is the axonal form, characterized by normal MNCV (Dyck et al, 1993). CMT2 has been linked to 3 loci on 1p35-36, 3q13-q22 and 7p14 (Ben Othmane et al, 1993;Kwon et al, 1995;Ionasescu et al, 1996). CMT1A is mostly caused by a duplication of the PMP22 gene on chromosome 17p11.2-p12 (Timmerman et al, 1992;Valentijn et al, 1992).…”
Section: Introductionmentioning
confidence: 99%
“…7,8 Most recently, a novel CMT2 locus (CMT2E) has been reported on chromosome 8p21, and a disease-causing mutation was found in the neurofilament light gene. 9 Until now, significant evidence for linkage to chromosome 1p35-p36 was reported only for five CMT2A families, from Japan or North America, 2,3 making it difficult to assess the geographic distribution and clinical features of this disorder. Identification of additional pedigrees with CMT2A would allow better results.…”
mentioning
confidence: 99%